Tag Archives: treatment
October 2011 Br J Cardiol 2011;18:219–22 doi:10.5837/bjc.2011.002
Patent foramen ovale: diagnosis, indications for closure and complications
Sudhakar George, David Hildick-Smith
(more…)
January 2008 Br J Cardiol 2008;15:48-50
Pharmacological secondary prevention in people with peripheral arterial disease compared to thosewith coronary artery disease: a missed opportunity
Simon EJ Janes, Joe West, Brian R Hopkinson, John T Walsh
Introduction Patients with peripheral arterial disease (PAD) have a high prevalence of modifiable risk factors for coronary artery disease (CAD).1 Consequently, they represent a suitable target for secondary prevention and there is strong evidence that this is beneficial.2–4 We aimed to establish whether people with PAD who are admitted to hospital receive equal pharmacological secondary prevention to those with CAD. Methods We prospectively recruited patients from 1st March 2003 until 1st June 2003 admitted to a vascular surgery ward (PAD) or cardiology ward (CAD) until discharge. All patients had symptomatic established disease and underw
November 2005 Br J Cardiol 2005;12:456-8
How would British stroke physicians diagnose and treat hypoxia in patients with acute stroke?
Christine Roffe, Amit Arora, Peter Crome, Richard Gray
No content available
September 2003 Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 82–AIC 88
Atrial fibrillation after coronary bypass surgery – pathophysiology, resource utilisation and management strategies
Joseph Alex, Gurpreet S Bhamra, Alex RJ Cale, Steven C Griffin, Michael E Cowen, Levent Guvendik
No content available
July 2003 Br J Cardiol 2003;10:297-304
Clinical usefulness of HDL cholesterol as a target to lower risk of coronary heart disease – Summary of evidence and recommendations of an expert group*
Frank M Sacks
No content available
For healthcare professionals only
